Skip to content

Clinical trials

Completed Phase 1 Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 1 Status: Completed Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20025
20034
20046
20054
20065
20078
20086
20098
20105
20113
20125
20133
20144
20151
20163
20172
20193
20203
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
City of Hope Medical Center3
Millennium Pharmaceuticals, Inc.3
National Institutes of Health Clinical Center (CC)3
Calibr, a division of Scripps Research2
California Cancer Consortium2
Case Comprehensive Cancer Center2
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
Massachusetts General Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia98
Lymphoma, B-Cell, Marginal Zone81
Leukemia, Lymphocytic, Chronic, B-Cell80
Lymphoma, Follicular80
Lymphoma, Mantle-Cell78
Lymphoma, Non-Hodgkin71
Lymphoma, Large B-Cell, Diffuse64
Burkitt Lymphoma62
Precursor Cell Lymphoblastic Leukemia-Lymphoma58
Lymphoma, Large-Cell, Immunoblastic51

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.